Most a short while ago, it has been identified that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in very similar parts as classical opioid receptors, it binds into a big selection of endogenous opioids. Not like most opioid receptors, this receptor https://lobow108wzb0.blogs100.com/profile